Garlon Polyfab reports net loss for Q4FY18
Garlon Polyfab Industries Limited reported a net loss of ₹111,664 for Q4FY18 with zero operational income. The annual net loss for FY18 was ₹197,556. The auditors issued an unmodified opinion on the results.

*this image is generated using AI for illustrative purposes only.
Garlon Polyfab Industries Limited reported a net loss of ₹111,664 for the quarter ended March 31, 2018 (Q4FY18). The company recorded zero income from operations during the period, with total expenses amounting to ₹111,664. For the full year ended March 31, 2018, the net loss was ₹197,556.
The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2018 at a meeting held on July 11, 2018. The results were reviewed by the Audit Committee in May 2018. The financial statements are prepared in compliance with Indian Accounting Standards (Ind-AS).
Financial Performance
The company's financial statements for the quarter and year ended March 31, 2018 show the following figures:
| Particulars | Quarter Ended 31-03-2018 (Audited) | Year Ended 31-03-2018 (Audited) |
|---|---|---|
| Income from operations | - | - |
| Other Income | - | - |
| Total Expenses | 111,664 | 197,556 |
| Net Profit/(Loss) for the period | (111,664) | (197,556) |
| Paid up equity share capital | 46,132,000 | 46,132,000 |
| Earnings Per Share (EPS) - Basic | (0.02) | (0.04) |
Auditor's Report
The Statutory Auditors, P. D. Agrawal & Co., conducted an audit of the financial results in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors issued an audit report with an unmodified opinion, stating that the results give a true and fair view of the financial information for the quarter and year ended March 31, 2018.
What strategies will Garlon Polyfab Industries implement to resume operations and generate revenue in the upcoming quarters?
How will the company manage its expenses to reduce the widening net loss in the next fiscal year?
Are there any planned capital infusions or restructuring efforts to stabilize the company's financial position?






























